Omics, mRNA and AI: Your top 10 reads of 2024
What were the trending topics of the year? Here, we run through DDW’s most read articles of 2024.
10: The future outlook for mRNA therapies
In this article for the Spring 2024 issue, DDW Editor Reece Armstrong explores the potential and future opportunities for mRNA-based therapies.
9: Key drug development trends and predictions for 2024
Dr Julie Warner, Vice President of Regulatory Affairs at drug development consultancy, Boyds, provides her expert insights into the key trends and developments expected to shape the global drug development industry this year.
8: Drug discovery hotspots: What is the secret to Switzerland’s success?
In a two-part article, DDW Senior Digital Content Editor Diana Spencer examines why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges.
7: Where are the global hotspots for biotech?
In this article from the Summer 2024 edition, Diana Spencer takes a world-tour of some of the key centres of innovation and finds that the future is looking rosy for the biotechnology sector.
6: Understanding the value of multi-omics
For another Summer 2024 feature, DDW Multimedia Editor Megan Thomas discusses the opportunity in the multi-omics sector by speaking with leading players and looking at the ways in which it can help us tackle disease.
5: How ready are we for radioligand therapies?
Reece Armstrong speaks to Jasminka Taleska, Director, RLT HCS Readiness and Policy at Novartis, about the opportunities radioligand therapies (RLTs) represent in treating cancer patients.
4: Can Singapore become a global hub for biotech?
In this article from the Winter 23/24 issue, Diana Spencer explores how the country is turning pioneering science into a successful biotech industry.
3: Unlocking AI in drug discovery: A roadmap to scalable solutions
Dr Mutlu Dogruel, Vice President of AI Solutions at Cresset, examines AI’s transformative potential, highlights the current challenges and introduces a series of potential solutions to implement AI in the drug discovery landscape successfully.
2: The killer instinct: Using natural killer therapy to treat Alzheimer’s
For this Winter 23/24 article, Reece Armstrong speaks to Dr Paul Song, MD, NKGen and Dr Vince DeOrchis, clinician, to find out more about the investigational natural killer therapy SNK01 and the benefit of using a patient’s own cells to treat Alzheimer’s.
1: Thirteen potential blockbuster drugs to watch in 2024
The year’s most popular article looks at thirteen new-to-market therapeutics and drugs poised to launch in 2024 that will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients, according to Clarivate’s annual Drugs to Watch report.
